Clinical trial
Therapeutic Efficacy of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome
NCT06417099 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Efficacy of Dihydroartemisinin in Patients With Polycystic Ovary Syndrome
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 24, 2024
- Completion date
- March 30, 2025
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.